Latest Convertible Debt News

Page 1 of 12
Akamai is seeking up to US$2.5 billion through convertible notes while temporarily loosening its leverage covenant and preparing for a US$1.15 billion debt maturity in 2027. The financing is also aimed at funding expansion of its Cloud Infrastructure Services business, but final pricing and potential dilution remain unresolved.
Sophie Babbage
Sophie Babbage
9 Nov 2026
Axtec has moved several proptech partnerships towards commercial rollout, but its September quarter cash position leaves just 0.58 quarters of estimated funding. The company is pursuing strategic investment and expects an R&D rebate, neither of which has been secured in the filing.
Victor Sage
Victor Sage
30 Oct 2026
Aldoro Resources has increased its Kameelburg Mineral Resource by 35% to 804.5 million tonnes, including a maiden 162.1Mt Indicated category. The Namibia project is now moving towards development studies, backed by A$4.3 million in convertible notes but still carrying substantial geological and funding risks.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Vertex Minerals has secured approval for round-the-clock underground operations at its Reward Gold Mine, removing the company’s stated biggest production constraint. The operational opening arrives alongside modest quarterly output, a sharply revised resource and reported cash coverage of less than half a quarter.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Dome Gold Mines has reached a regulatory milestone at its Sigatoka heavy mineral sands project, but remains suspended from trading with no cash on hand and its annual audit unfinished. The company is seeking up to A$3 million through convertible notes while it negotiates funding for valuation work and working capital.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Peninsula Energy has reported materially stronger flow rates at several Lance header houses and reconfirmed its 500,000 to 600,000-pound CY2027 production target. The operational gains come alongside a US$30 million convertible debt draw, US$11.5 million of quarterly operating cash outflows and only 2.9 quarters of estimated funding at the current burn rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.
Ada Torres
Ada Torres
29 Oct 2026
Mindax ended FY2026 with just A$83,116 in cash and a A$2.49 million loss before tax, prompting its auditor to highlight material uncertainty over the company’s ability to continue as a going concern. Post-year-end funding has lifted cash to A$4.079 million, although much of that support remains tied to convertible debt and approvals.
Maxwell Dee
Maxwell Dee
29 Oct 2026
PARKD’s FY26 annual report puts the company’s funding position under sharper scrutiny after a steep revenue decline, a $1.26 million loss and $367,714 in cash. Its east-coast expansion produced new facilities, partnerships and demonstrations, but the next test is converting that platform into contracted work quickly enough.
Victor Sage
Victor Sage
28 Oct 2026
Peninsula Energy’s low-pH uranium restart delivered stronger grades but struggled to move enough solution through the Lance wellfields, forcing guidance to be withdrawn and triggering a US$50.1 million impairment. Auditors flagged material uncertainty over the company’s ability to continue as a going concern, despite fresh funding and a reconfirmed CY2027 production target.
Maxwell Dee
Maxwell Dee
29 Sept 2026
PainChek grew recurring revenue, implemented licences and customer sites in FY2026, but its $8.94 million loss and $9.24 million operating cash outflow prompted an explicit going-concern warning from its auditor. The company is now betting that US deployments and a sharper commercial focus can convert market access into cash-generating growth.
Victor Sage
Victor Sage
23 Sept 2026
NEXTDC is seeking A$1.1 billion from institutional investors through subordinated convertible notes, adding to its funding capacity for an increasingly capital-intensive data centre pipeline. The deal offers a low indicative coupon, but introduces future dilution risk and could create short-term share price pressure through associated hedging activity.
Victor Sage
Victor Sage
9 Sept 2026

Browse the archive

Full archive